Sheel Biotech Limited (NSE:SHEEL)
India · Delayed Price · Currency is INR 60.00
-2.05 (-3.30%)
At close: Aug 21, 2026
Sheel Biotech Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 21.83 | 4.64 | 6.03 | 2.11 | 3.11 |
Short-Term Investments | - | 16.06 | 12.27 | 12.59 | - |
Cash & Short-Term Investments | 21.83 | 20.7 | 18.3 | 14.7 | 3.11 |
Cash Growth | 5.46% | 13.12% | 24.46% | 372.66% | -93.23% |
Accounts Receivable | 618.05 | 550.79 | 577.01 | 560.46 | 647.07 |
Other Receivables | - | 0.26 | - | - | - |
Receivables | 647.66 | 551.05 | 577.01 | 560.46 | 647.07 |
Inventory | 295.65 | 393.85 | 327.74 | 193 | 118.28 |
Prepaid Expenses | - | 0.78 | 0.29 | 0.46 | 0.75 |
Other Current Assets | 313.13 | 44.54 | 30.66 | 59.36 | 30.75 |
Total Current Assets | 1,278 | 1,011 | 954.01 | 827.97 | 799.96 |
Property, Plant & Equipment | 129.2 | 74.74 | 72.21 | 79.11 | 77.64 |
Long-Term Investments | 7.92 | 7.92 | 8.02 | 8.02 | 8.02 |
Other Intangible Assets | 0.12 | 0.14 | 0.16 | 0.19 | 0.28 |
Long-Term Deferred Tax Assets | 1.05 | 0.49 | 1.07 | - | - |
Other Long-Term Assets | 41.29 | 38.62 | 24 | 23.66 | 46.73 |
Total Assets | 1,458 | 1,133 | 1,059 | 938.94 | 932.63 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 30.6 | 41.41 | 45.86 | 82.03 | 83.4 |
Accrued Expenses | 1.98 | 10.33 | 9.5 | 8.82 | 10.18 |
Short-Term Debt | 77.35 | 123.43 | 130.12 | 78.59 | 91.53 |
Current Portion of Long-Term Debt | - | 1.95 | 2.59 | 18.7 | 4.69 |
Current Income Taxes Payable | - | 21.29 | 19.9 | 13.24 | - |
Other Current Liabilities | 59.8 | 41.75 | 18.1 | 3.78 | 0 |
Total Current Liabilities | 169.73 | 240.16 | 226.07 | 205.16 | 189.81 |
Long-Term Debt | 12.44 | 48.23 | 102.68 | 94.41 | 139.61 |
Pension & Post-Retirement Benefits | 5.76 | 5.9 | 3.81 | 2.91 | - |
Long-Term Deferred Tax Liabilities | - | - | - | 1.05 | 0.36 |
Total Liabilities | 187.93 | 294.28 | 332.56 | 303.53 | 329.77 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 203.53 | 149.53 | 41.44 | 41.44 | 41.44 |
Additional Paid-In Capital | - | 19.74 | 4 | 4 | - |
Retained Earnings | - | 669.28 | 681.47 | 589.98 | 561.42 |
Comprehensive Income & Other | 1,066 | - | - | - | - |
Shareholders' Equity | 1,270 | 838.54 | 726.9 | 635.42 | 602.86 |
Total Liabilities & Equity | 1,458 | 1,133 | 1,059 | 938.94 | 932.63 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 89.79 | 173.61 | 235.4 | 191.71 | 235.83 |
Net Cash (Debt) | -67.96 | -152.91 | -217.1 | -177.01 | -232.72 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -3.87 | -10.37 | -14.97 | -12.20 | -16.05 |
Filing Date Shares Outstanding | 20.65 | 20.35 | 14.5 | 4.14 | 4.14 |
Total Common Shares Outstanding | 20.65 | 14.95 | 14.5 | 4.14 | 4.14 |
Working Capital | 1,109 | 770.76 | 727.93 | 622.81 | 610.15 |
Book Value Per Share | 61.51 | 56.08 | 50.12 | 153.34 | 145.49 |
Tangible Book Value | 1,270 | 838.4 | 726.74 | 635.23 | 602.58 |
Tangible Book Value Per Share | 61.50 | 56.07 | 50.11 | 153.30 | 145.42 |
Land | - | 20.76 | 20.76 | 20.76 | 20.76 |
Buildings | - | 38.11 | 39.4 | 39.4 | 37.98 |
Machinery | - | 152.44 | 140.06 | 137.12 | 116.18 |
Construction In Progress | - | - | - | - | 1.41 |